TY - JOUR AU - Siegel, R. AU - Ma, J. AU - Zou, Z. PY - 2014 DA - 2014// TI - Cancer statistics,2014 JO - Cancer VL - 64 ID - Siegel2014 ER - TY - JOUR AU - Ce, B. AU - Xia, Z. PY - 2015 DA - 2015// TI - Neoadjuvant chemotherapy in the treatment of advanced ovarian cancer JO - J Pract Obstet Gynecol VL - 04 ID - Ce2015 ER - TY - JOUR AU - Bristow, R. E. AU - Duska, L. R. AU - Lambrou, N. C. PY - 2000 DA - 2000// TI - A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography JO - Cancer VL - 89 UR - https://doi.org/3.0.CO;2-A DO - 3.0.CO;2-A ID - Bristow2000 ER - TY - JOUR AU - Vorgias, G. AU - Iavazzo, C. AU - Savvopoulos, P. PY - 2009 DA - 2009// TI - Can the preoperative ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?A single institution cohort study JO - Gynecol Oncol VL - 112 UR - https://doi.org/10.1016/j.ygyno.2008.09.020 DO - 10.1016/j.ygyno.2008.09.020 ID - Vorgias2009 ER - TY - JOUR AU - Colombo, N. AU - Van Gorp, T. AU - Parma, G. PY - 2006 DA - 2006// TI - Ovarian cancer JO - Oncol Hematol VL - 60 ID - Colombo2006 ER - TY - JOUR AU - Kang, S. PY - 2009 DA - 2009// TI - Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies JO - Surg Oncol VL - 16 UR - https://doi.org/10.1245/s10434-009-0558-6 DO - 10.1245/s10434-009-0558-6 ID - Kang2009 ER - TY - JOUR AU - McGuire, W. P. AU - Hoskins, W. J. AU - Brady, M. F. PY - 1996 DA - 1996// TI - Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer JO - N Engl J Med VL - 334 UR - https://doi.org/10.1056/NEJM199601043340101 DO - 10.1056/NEJM199601043340101 ID - McGuire1996 ER - TY - JOUR AU - Xuemei, J. AU - Huihua, D. AU - Shuyu, W. AU - Wei, X. AU - Zhihong, Z. PY - 2010 DA - 2010// TI - The effect of neoadjuvant chemotherapy in gynecologic malignancies JO - Jiangsu Med VL - 09 ID - Xuemei2010 ER - TY - JOUR AU - Tongwei, R. PY - 2009 DA - 2009// TI - Application of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer JO - Chinese and Foreign Medical VL - 22 ID - Tongwei2009 ER - TY - JOUR AU - Ying, Z. AU - Yingli, Z. AU - Ping, Z. PY - 2014 DA - 2014// TI - Progress in Neoadjuvant Chemotherapy for Advanced Ovarian Cancer JO - J Oncol VL - 11 ID - Ying2014 ER - TY - JOUR AU - Obeidat, B. AU - Latimer, J. PY - 2004 DA - 2004// TI - Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level JO - Gynecol Obstet Investig VL - 57 UR - https://doi.org/10.1159/000076236 DO - 10.1159/000076236 ID - Obeidat2004 ER - TY - JOUR AU - Loizzi, V. AU - Cormio, G. AU - Resta, L. PY - 2005 DA - 2005// TI - Neoadjuvant chemotherapy in advanced ovarian cancer:a case-control study[J] JO - Int J Gynecol Cancer VL - 15 UR - https://doi.org/10.1111/j.1525-1438.2005.15206.x DO - 10.1111/j.1525-1438.2005.15206.x ID - Loizzi2005 ER - TY - JOUR AU - Wright, J. D. AU - Ananth, C. V. AU - Tsui, J. PY - 2014 DA - 2014// TI - Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer[J] JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28508 DO - 10.1002/cncr.28508 ID - Wright2014 ER - TY - JOUR AU - Fago-Olsen, C. L. AU - Ottesen, B. AU - Kehlet, H. PY - 2014 DA - 2014// TI - Dose neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients?A nationwide Danish study[J] JO - Gynecol Oncol VL - 132 UR - https://doi.org/10.1016/j.ygyno.2013.11.035 DO - 10.1016/j.ygyno.2013.11.035 ID - Fago-Olsen2014 ER - TY - JOUR AU - Bristow, R. E. AU - Tomacruz, R. S. AU - Armstrong, D. K. PY - 2002 DA - 2002// TI - Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.20.5.1248 DO - 10.1200/JCO.2002.20.5.1248 ID - Bristow2002 ER - TY - JOUR AU - Schwart, P. E. PY - 2009 DA - 2009// TI - Contemporary considerations for neoadjuvant chemotherapy in primary ovarian cancer[J].Gynecology JO - Cancers VL - 11 ID - Schwart2009 ER -